NeuroVive Pharmaceutical AB SMA 200
Что обозначает SMA 200 в NeuroVive Pharmaceutical AB?
SMA 200 NeuroVive Pharmaceutical AB является $0 -7.26%
Какое определение для SMA 200?
SMA 200 - это средняя цена акций за последние 200 дней, рассчитанная как невзвешенное среднее значение предыдущих 200 цен закрытия акций.
Simple moving average of 200 days for a stock is an unweighted moving average over the past 200 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.
Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.
SMA 200 компаний в Health Care сектор на OTC по сравнению с NeuroVive Pharmaceutical AB
Что делает NeuroVive Pharmaceutical AB?
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
Компании с sma 200 похож на NeuroVive Pharmaceutical AB
- 8I имеет SMA 200 из AUD$0 -29.63%
- Perk Labs имеет SMA 200 из $0 +58.24%
- Latecoere S.A имеет SMA 200 из €0 -43.93%
- BMG Resources имеет SMA 200 из AUD$0 -52.24%
- Aspermont имеет SMA 200 из AUD$0 -77.62%
- Athersys Inc имеет SMA 200 из $0 +89.52%
- NeuroVive Pharmaceutical AB имеет SMA 200 из $0 -7.26%
- Westar Resources имеет SMA 200 из AUD$0 -53.36%
- Otto имеет SMA 200 из AUD$0 +1.84%
- Celsius Resources имеет SMA 200 из AUD$0 +1.74%
- Sunstone Metals имеет SMA 200 из AUD$0 -80.15%
- O.A.T имеет SMA 200 из $0 -170.37%
- Sultan Resources имеет SMA 200 из AUD$0 -80.77%